Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas

28 Nov 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19944969
DOI: 10.1016/j.nec.2009.08.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant GliomasPMID 19944969Read ↗

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomasSemantic proximity Read ↗

A Specific Peptide Vaccine Against IDH1(R132H) Glioma.Semantic proximity Read ↗

A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma.Semantic proximity Read ↗

Epidermal growth factor receptor and variant III targeted immunotherapySemantic proximity Read ↗

Design of a novel multiepitope vaccine against glioblastoma by in silico approachesSemantic proximity Read ↗

Mutation-specific T cells for immunotherapy of gliomas.Semantic proximity Read ↗

Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response.Semantic proximity Read ↗

Prospect of rindopepimut in the treatment of glioblastomaSemantic proximity Read ↗

Vaccine shows promise in diffuse midline glioma.Semantic proximity Read ↗

The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme.Semantic proximity Read ↗

Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escapeSemantic proximity Read ↗

Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.